Enhanced Passive Safety Surveillance of the Seasonal Trivalent Influenza Vaccine (Enzira & generic Seqirus influenza vaccine) for the 2016-17 influenza season.

Trial Profile

Enhanced Passive Safety Surveillance of the Seasonal Trivalent Influenza Vaccine (Enzira & generic Seqirus influenza vaccine) for the 2016-17 influenza season.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Influenza virus vaccine (Afluria) (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Seqirus
  • Most Recent Events

    • 15 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top